Condition

Peritoneal Cancer clinical trials and research

• 17Clinical trials
• 14Countries

Newest Peritoneal Cancer clinical trials

All recruiting trials (17)

• Raludotatug Deruxtecan With or Without Bevacizumab as First‑Line Maintenance in Advanced Ovarian Cancer

  This trial tests whether maintenance therapy with raludotatug deruxtecan, with or without bevacizumab, helps people with advanced ovarian, fallopian tube, or primary peritoneal cancer live longer without the cancer growing after initial treatment.

  Recruiting at 13 sites Phase 3 Merck Sharp & Dohme LLC · Washington D.C., District of Columbia and 12 other locations · NCT07776691

• Raludotatug Deruxtecan with or without Bevacizumab for advanced ovarian, peritoneal, or fallopian tube cancer

  This trial tests whether adding raludotatug deruxtecan (R-DXd) to or without bevacizumab helps people with advanced ovarian cancer that progressed after PARP-inhibitor maintenance.

  Recruiting at 7 sites Phase 3 Merck Sharp & Dohme LLC · Fountain Valley, California and 6 other locations · NCT07743164

• Personalized timing of interval debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.

  This study will see if using the CA125 drop rate (KELIM) to decide when to do interval debulking surgery helps people with advanced ovarian, fallopian tube, or peritoneal cancer who are receiving neoadjuvant chemotherapy.

  Recruiting Phase 2 The University of Hong Kong · Hong Kong · NCT07022535

• Direct injection of a modified vaccinia virus (vvDD-hIL2) into abdominal and gastrointestinal tumors

  This trial will try a single direct injection of a modified vaccinia virus (vvDD-hIL2) into abdominal tumors to see if it is safe for adults with advanced metastatic gastrointestinal or peritoneal cancers who have not responded to standard treatments.

  Recruiting Phase 1 Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Pittsburgh, Pennsylvania · NCT07001592

• Clinical and biological database for people with advanced ovarian, peritoneal, or fallopian tube cancer

  This project will collect clinical information, blood and tumor samples, and regular quality-of-life questionnaires from people newly diagnosed with advanced ovarian, peritoneal, or fallopian tube cancer to see if combining patient and tumor features can predict overall survival.

  Recruiting Centre Oscar Lambret · Lille · NCT06969833

• Fluzoparib with or without Bevacizumab for treating advanced ovarian cancer

  This study is testing whether a new drug called Fluzoparib, alone or with another drug called Bevacizumab, can help people with advanced ovarian cancer caused by BRCA1/2 mutations do better than standard chemotherapy.

  Recruiting Phase 2 Qilu Hospital of Shandong University · Jinan, Shandong · NCT06735326

• Using blood volume management during surgery for ovarian cancer patients

  This study tests if a blood management technique called acute normovolemic hemodilution can help women with advanced ovarian cancer during surgery by reducing the need for blood transfusions and improving safety.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT06290193

• Registry development for patients with gynecologic cancer in Korea

  This study is collecting information from women with gynecologic cancers in Korea to see how their treatments and outcomes can be improved.

  Recruiting Asan Medical Center · Seoul · NCT05912972

• Combination therapy using Mirvetuximab Soravtansine and Olaparib for ovarian cancer maintenance

  This study is testing a new combination treatment with Mirvetuximab Soravtansine and Olaparib to see if it helps women with certain types of recurrent ovarian cancer stay healthy after their initial treatment.

  Recruiting at 6 sites Phase 2 University of Colorado, Denver · Irvine, California and 5 other locations · NCT05887609

• Investigating infections after spleen removal in cancer patients

  This study looks at cancer patients who have had their spleen removed to see how often they get infections and how well they follow their antibiotic prescriptions.

  Recruiting Hampshire Hospitals NHS Foundation Trust · Basingstoke, Hampshire · NCT05718726

• Adaptive chemotherapy approach for relapsed ovarian cancer

  This study is testing if adjusting the dose of carboplatin based on a blood marker can help women with relapsed ovarian cancer feel better and have fewer side effects from treatment.

  Recruiting Phase 2 University College, London · London · NCT05080556

• Combining ZEN003694 and Talazoparib for Recurrent Ovarian Cancer

  This study is testing if combining two cancer drugs, ZEN003694 and talazoparib, can help people with recurrent ovarian cancer feel better after other treatments haven’t worked.

  Recruiting Phase 2 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT05071937

• Comparing Niraparib alone versus Niraparib with Bevacizumab for advanced ovarian cancer treatment

  This study is testing whether adding a drug called bevacizumab to the treatment with niraparib can help people with newly diagnosed advanced ovarian cancer do better than with niraparib alone.

  Recruiting at 62 sites Phase 3 AGO Study Group · Amberg and 64 other locations · NCT05009082

• Using virtual reality to help manage pain in GI cancer patients

  This study is testing if virtual reality can help people with GI cancer manage their severe abdominal pain better than standard treatments.

  Recruiting Cedars-Sinai Medical Center · Los Angeles, California · NCT04907643

• Using a microdevice to measure tumor response in ovarian and related cancers

  This study is testing a tiny device that will be placed in tumors of patients with advanced ovarian and related cancers to see how well different chemotherapy drugs work before surgery.

  Recruiting at 2 sites Phase 1 Brigham and Women's Hospital · Boston, Massachusetts and 1 other locations · NCT04701645

• Evaluating ZN-c3 for patients with ovarian cancer

  This study is testing a new treatment called ZN-c3 combined with other chemotherapy drugs to see if it is safe and effective for people with advanced ovarian cancer.

  Recruiting at 12 sites Phase 1 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc · Aurora, Colorado and 34 other locations · NCT04516447

• Testing BP1001-A for advanced or recurrent solid tumors

  This study is testing a new drug called BP1001-A to see if it can safely help people with advanced or recurring solid tumors when used alone or with another medication called paclitaxel.

  Recruiting at 4 sites Phase 1 Bio-Path Holdings, Inc. · Silver Spring, Maryland and 3 other locations · NCT04196257

Related topics

Quick answers

How many Peritoneal Cancer clinical trials are recruiting right now?

17, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 14 countries. The most sites are in United States (10 trials), South Korea (3 trials), United Kingdom (3 trials), France (2 trials), Israel (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 6, Phase 1: 4, Phase 3: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →